These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2160123)

  • 41. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
    Maher L; Chant K; Jalaludin B; Sargent P
    J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Extent of HIV infection and AIDS among drug addicts].
    Andersen JS; Larsen SO; Fallov J; Saelan H
    Ugeskr Laeger; 1992 Aug; 154(35):2368-71. PubMed ID: 1413152
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seroepidemiology of hepatitis A, B, and D viruses and human T-lymphocyte tropic viruses in Japanese drug abusers.
    Kiyosawa K; Oofusa H; Saitoh H; Sodeyama T; Tanaka E; Furuta S; Itoh S; Ogata H; Kobuchi H; Kameko M
    J Med Virol; 1989 Nov; 29(3):160-3. PubMed ID: 2559157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A cross sectional serological study of the co-infection of hepatitis B virus, hepatitis C virus and human immunodeficiency virus amongst a cohort of IDUs at Delhi.
    Baveja UK; Chattopadhya D; Khera R; Joshi PM
    Indian J Med Microbiol; 2003; 21(4):280-3. PubMed ID: 17643045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of markers of hepatotropic viruses among drug addicts in Warsaw, Poland.
    Laskus T; Radkowski M; Lupa E; Slusarczyk J; Cianciara J; Halama G; Nowicka R
    J Hepatol; 1992 May; 15(1-2):114-7. PubMed ID: 1324268
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The virology and serology of hepatitis: an overview.
    Teo CG
    Commun Dis Rep CDR Rev; 1992 Sep; 2(10):R109-14. PubMed ID: 1284925
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevalence of hepatitis B virus, delta agent and human immunodeficiency virus infections in drug addicts.
    Bailly D; Dervaux A; Servant D; Parquet PJ
    Biomed Pharmacother; 1989; 43(6):431-7. PubMed ID: 2686771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Follow up of a cohort of intravenous heroin users in north and south central Dublin and in Dun Laoghaire.
    Dean G; Lavelle P; O'Kelly FD; Power B; Hillery I
    Ir Med J; 1992 Mar; 85(1):9-10. PubMed ID: 1568857
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Viral hepatitis and drugs: a continuing problem.
    Patti AM; Santi AL; Pompa MG; Giustini C; Vescia N; Mastroeni I; Fara GM
    Int J Epidemiol; 1993 Feb; 22(1):135-9. PubMed ID: 8449633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How and why AIDS changed drug policy in Switzerland.
    Somaini B; Grob P
    J Public Health Policy; 2012 Aug; 33(3):317-24. PubMed ID: 22895501
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence of blood-borne viruses among intravenous drug users and alcoholics in Hiroshima, Japan.
    Ichimura H; Kurimura O; Tamura I; Tsukue I; Tsuchie H; Kurimura T
    Int J STD AIDS; 1995; 6(6):441-3. PubMed ID: 8845404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prevalence of hepatitis A virus and hepatitis B virus immunity in patients with polymerase chain reaction-confirmed hepatitis C: implications for vaccination strategy.
    Siddiqui F; Mutchnick M; Kinzie J; Peleman R; Naylor P; Ehrinpreis M
    Am J Gastroenterol; 2001 Mar; 96(3):858-63. PubMed ID: 11280565
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Exposure to hepatitis B and C and to HTLV-1 and 2 among Israeli drug abusers in Jerusalem.
    Maayan S; Shufman EN; Engelhard D; Shouval D
    Addiction; 1994 Jul; 89(7):869-74. PubMed ID: 8081185
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intravenous drug addicts: a high risk group for infection with human immunodeficiency virus, hepatitis viruses, cytomegalo virus and bacterial infections in Alexandria Egypt.
    el-Ghazzawi E; Drew L; Hamdy L; El-Sherbini E; Sadek Sel-D; Saleh E
    J Egypt Public Health Assoc; 1995; 70(1-2):127-50. PubMed ID: 17214204
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis infection among adolescents resident in Melbourne Juvenile Justice Centre: risk factors and challenges.
    Ogilvie EL; Veit F; Crofts N; Thompson SC
    J Adolesc Health; 1999 Jul; 25(1):46-51. PubMed ID: 10418885
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Strategies for enhancing existing studies of the natural history of HIV-1 infection among drug users.
    Chitwood DD; Comerford M; Trapido EJ
    NIDA Res Monogr; 1991; 109():9-28. PubMed ID: 1753993
    [No Abstract]   [Full Text] [Related]  

  • 57. HIV-1 infection in injection drug users.
    Cohn JA
    Infect Dis Clin North Am; 2002 Sep; 16(3):745-70. PubMed ID: 12371125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prevalence of blood-borne pathogens among 275 trauma patients : A prospective observational study].
    Wicker S; Rabenau HF; Scheller B; Marzi I; Wutzler S
    Unfallchirurg; 2016 Aug; 119(8):648-53. PubMed ID: 26537969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hepatitis A in drug addicts].
    Laskus T; Lupa E; Radkowski M; Slusarczyk J
    Wiad Lek; 1992 Jun; 45(11-12):423-6. PubMed ID: 1441523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Nature of type A and type B hepatitis viruses and their diagnosis and control].
    Zuckerman AJ
    Rev Esp Enferm Apar Dig; 1978 Apr; 53(2):165-72. PubMed ID: 209504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.